This study is not yet accepting patients

Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression

a study on Immunosuppresion

Summary

Dates
study started
completion around
Principal Investigator
by Gabriela Schmajuk, MD MS (ucsf)
Headshot of Gabriela Schmajuk
Gabriela Schmajuk

Description

Summary

The goal of this wait-list control trial is to learn if having access to a new dashboard displaying information about immunosuppressed Veterans missing vaccinations for Shingrix can improve Shingrix vaccination rates at VA facilities.

The main question[s] it aims to answer is: Will vaccination rates improve more rapidly for facilities with access to the dashboard compare to facilities without access? VA facility personnel will be granted access to the dashboard and outcomes (vaccination rates) will be measured using electronic health record data.

Official Title

VA Quality Improvement Research and Training Initiative

Details

Assignment of the intervention will occur at the facility level. Outcomes (vaccination) will be assessed for patients cared for at each facility.

Keywords

Immunosuppresion, Wait-list control randomized trial, Access to Shingrix dashboard, Early dashboard access

Eligibility

You can join if…

  • In order to be included in the study, clinicians need to work at a VHA facility and have access to the electronic health record.

You CAN'T join if...

  • None.

Lead Scientist at University of California Health

  • Gabriela Schmajuk, MD MS (ucsf)
    Dr. Schmajuk is Chief of Rheumatology at the San Francisco VA Health Care System and a Professor in the Division of Rheumatology, Department of Medicine at UCSF. She received her undergraduate degree from Harvard, her MD from the University of Pennsylvania, and her Masters in Epidemiology from Stanford.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06596148
Study Type
Interventional
Participants
Expecting 130 study participants
Last Updated